PetVivo Holdings, Inc. (PETV)
OTCMKTS: PETV · Delayed Price · USD
0.436
+0.036 (9.00%)
Jul 2, 2024, 3:50 PM EDT - Market closed

Company Description

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals.

Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses.

The company's pipeline products also include therapeutic devices for veterinary and human clinical applications.

PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

PetVivo Holdings, Inc.
PetVivo Holdings logo
Country MN
Industry Medical Devices
Sector Healthcare
Employees 25
CEO John Lai

Contact Details

Address:
5251 Edina Industrial Blvd
Edina, Minnesota 55439
United States
Phone (952) 217-4952
Website petvivo.com

Stock Details

Ticker Symbol PETV
Exchange OTCMKTS
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001512922
CUSIP Number 716817408
ISIN Number US7168174081
Employer ID 99-0363559
SIC Code 3841

Key Executives

Name Position
John Lai Chief Executive Officer, President and Director
Randall A. Meyer Chief Operating Officer
Garry N. Lowenthal Chief Financial Officer
Randy Wenthold Chief Science Officer
John F. Dolan General Counsel, Chief Business Development Officer and Secretary
Gary DeMel Executive Vice President of Business Development
Russell Siakel Director of Marketing

Latest SEC Filings

Date Type Title
Jun 28, 2024 8-K Current Report
Jun 28, 2024 10-K Annual Report
Jun 25, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
May 30, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
May 15, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
May 13, 2024 8-K Current Report
May 9, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
May 1, 2024 8-K Current Report
Apr 26, 2024 8-K Current Report
Apr 22, 2024 8-K Current Report